Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Juvederm Users: Cosmetic Dermatologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
Keith DenklerAugust 13, 2007
Xiaflex will dramatically replace surgery
Analysis of: The Journal of Hand Surgery Publishes Initial Phase III Data on Xiaflex (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's Contracture | pharmalive.com
Author: Keith Denkler, Associate Clinical Professor of Plastic Surgery, UNIVERSITY OF CALIFORNIA SAN FRANCISCO
The efficacy of Xiaflex to not only open up the bent fingers of Dupuytren's, but its ability to diminish recurrence will dramatically decrease surgery rate for Dupuytren's. 
August 13, 2007
TEARS OF THE RETINAL PIGMENT EPITHELIUM: An Old Problem in a New Era.
Analysis of: Tears in the Retinal Pigment Epithelium: A Complication Associated with the New Macular Degeneration Treatments | pt.wkhealth.com
Author: GLG Expert Contributor
Tears of the retinal pigment epithelium (RPE) may develop during the course of anti-VEGF therapy for age-related macular degeneration (AMD) related pigment epithelial detachment (PED), according to a study published in the June issue of Retina.  A total of 33 cases of RPE tear after treatment with...
July 30, 2007
They have improved, but they are not the holy grail
Analysis of: Recurrence of Spider Angiomas After Laser Treatment | dermatology.jwatch.org
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
Lasers are better than they were 10 years ago.  Especially for vascular lesions; however, they are not all purpose machines that can do everything, as evidenced by new ones every year.
July 19, 2007
Sculptra: proceed with caution
Analysis of: Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results | www.newswire.ca
Author: GLG Expert Contributor
I was trained on the use of New-fill in London about 5 years ago. My impression then was of a rather complicated to use product, compared to the existing fillers in the market like Hyaluronic Acid.
July 12, 2007
I would love it
Analysis of: Norwegian hacker says he can bypass AT&T on iPhone | today.reuters.com
Author: Michael Bain, Plastic and Reconstructive Physician, Michael A Bain, MD
It would be great to get an unlocked i-phone...
Sunil DhawanJuly 12, 2007
Vaniqa's effect on laser hair removal
Analysis of: Laser Hair Removal Enhanced With Eflornithine Cream | www.medscape.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
I do not believe that Vaniqa will have a negative effect on Laser hair removal as its efficacy is only temporary. In fact we use it as an adjunct for patients with resistant areas. Its use may actually enhance the use of Laser devices as they offer permanence. The products use may be increasing as more...
July 10, 2007
AMO makes Bid for Bausch and Lomb
Analysis of: AMO outbids private equity firm for Bausch & Lomb | www.osnsupersite.com
Author: GLG Expert Contributor
In this news release presented today, this leading ophthalmic journal reports that AMO has presented the highest bid for the purchase of Bausch and Lomb.  
July 2, 2007
COST EFFECTIVENESS OF AVASTIN MAY BE HUGE ….VERDICT STILL OUT ON ITS SAFETY AND EFFECTIVENESS FOR MACULAR DEGENERATION
Analysis of: Costs of Visual Benefits in Treating Age-Related Macular Degeneration | www.ophsource.org
Author: GLG Expert Contributor
Dr Smiddy reviewed age-related macular degeneration studies to evaluate the cost for the visual benefit of various treatment approaches, and then compared them with the costs for treating other retinal conditions. This study founds costs for treating wet macular degeneation could be as high as $9000...
July 2, 2007
PDT MAY CONTINUE TO SERVE A ROLE IN THE TREATMENT OF WET MACULAR DEGENERATION
Analysis of: Verteporfin and Intravitreal Bevacizumab Combination Treatment | www.ophsource.org
Author: GLG Expert Contributor
In a study of patients with choroidal neovascularization due to age-related macular degeneration, Lazic and Gabric demonstrated that improvements in vision and reduction of central macular thickness after one month and their maintenance over three months are more significant after verteporfin photodynamic...
July 2, 2007
SMOKING INCREASES RISK OF BLINDNESS DUE TO MACULAR DEGENERATION
Analysis of: European Eye Study Links Cigarette Smoking to Age-Related Macular Degeneration | www.ophsource.org
Author: GLG Expert Contributor
The European Eye Study (EUREYE) investigated 4,750 randomly sampled people over age 65 and examined the association between cigarette smoking and age-related macular degeneration and concluded that there is a postive correlation to smoking and blindness from macular degeneration.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next91 to 100 of 188

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747